EE153 Budget Impact Analysis of Introducing Mobocertinib for Locally Advanced or Metastatic Epidermal Growth Factor Receptor Exon 20 Insertion-Positive Non-Small-Cell Lung Cancer in the United States from the Payer Perspective

Saved in:
Bibliographic Details
Published in:Value in health 2022-07, Vol.25 (7), p.S364
Main Authors: Hernandez, LG, Young, M
Format: Article
Language:English
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:
ISSN:1098-3015
DOI:10.1016/j.jval.2022.04.402